ADPT News and Press, Adaptive Biotechnologies Corporation

2026-02-06 12:15:23 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript Adaptive Biotechnologies Corporation 2025 Q4 - Results - Earnings Call Presentation Adaptive Biotechnologies Corporation (ADPT) Presen...

2026-02-06 12:14:21 ET Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call February 5, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript

2026-02-05 21:07:36 ET Image source: The Motley Fool. Feb. 5, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-05 16:15:31 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Tra...

SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...

Exponent Inc. (EXPO) is expected to report $0.47 for Q4 2025 Peabody Energy Corporation (BTU) is expected to report $0.08 for Q4 2025 Affirm Holdings Inc. (AFRM) is expected to report $0.28 for Q2 2026 Power Integrations Inc. (POWI) is expected to report $0.03 for Q4 2025 Alpha an...

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial...

2026-01-12 22:35:58 ET Adaptive Biotechnologies Corporation (ADPT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 7:30 PM EST... Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annua...

2026-01-12 07:50:26 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle Adaptive Biotechnologies Corporation 2025 Q3 - Results - Earnings Call Presentation Adaptive Biotechnologies Corporation (ADPT) Q3 2025 E...

SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced preliminary, unaudited r...